Publications by authors named "K Fabian"

Claim this Profile
T
TIME for Endometrial Cancer: Advancements and Challenges in Therapeutic Targets for the Endometrial Cancer Tumor Immune Microenvironment.
Margaret R Pruitt, Kellsye P Fabian, Jung-Min Lee, James W Hodge

Cancer Immunol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATR inhibitor tuvusertib (M1774) sensitizes prostate carcinoma to natural killer cell-mediated cytotoxicity, which is further augmented by the IL-15 receptor superagonist N-803.
Cailyn A Lee, Jeffrey Schlom, James W Hodge, Kellsye P Fabian

Cancer Immunol Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Intraindividual Comparison of Automated Customized Ray-Tracing-Guided versus Wavefront-Optimized LASIK.
Ramin Khoramnia, Tadas Naujokaitis, Louise Blöck, Katharina Fabian, Lucy Joanne Kessler

Ophthalmology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models.
Francesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, Michelle R Padget, Jonelle K Lee

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New generation capsaicin-diclofenac containing, silicon-based transdermal patch provides prolonged analgesic effect in acute and chronic pain models.
Kitti Göntér, Szabolcs László, Valéria Tékus, Ágnes Dombi, Katalin Fábián

Eur J Pharm Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis